Literature DB >> 31284780

Baicalein blocked cervical carcinoma cell proliferation by targeting CCND1 via Wnt/β-catenin signaling pathway.

Xiulian Xia1, Jiyi Xia2, Hai Yang1, Yan Li3, Shengyue Liu1, Yong Cao3, Li Tang3, Xiaolan Yu1.   

Abstract

The purpose of this study was to investigate the inhibitory effect of baicalein on the proliferation of cervical carcinoma cells and stimulate cervical carcinoma cells with baicalein. MTT method was used to observe cell proliferation. Flow cytometry was used to observe cell cycle, and gene technology was used to observe the expression of corresponding genes at the level of gene and protein. β-catenin activity was assessed using Western blot and ChIP. Baicalein suppressed cervical carcinoma cell HeLa proliferation by enhancing the activity of caspase-3. Baicalein blocked cell cycle at G0/G1 stage by inhibiting the expression of some genes. At the same time, it can prevent the nuclear translocation of β-catenin and inhibit the activity of Wnt. When the Wnt signaling pathway is increased, the proliferation of HeLa cells is inhibited, and apoptosis is promoted in this way. In conclusion, it indicated that baicalein inhibits cervical carcinoma progression by targeting CCND1 via Wnt/β-catenin signaling pathway.

Entities:  

Keywords:  Baicalein; CCND1; Wnt/β-catenin pathway; cervical carcinoma; proliferation

Year:  2019        PMID: 31284780     DOI: 10.1080/21691401.2019.1636055

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  9 in total

Review 1.  Latest research progress on anticancer effect of baicalin and its aglycone baicalein.

Authors:  Lin Wang; Ting Feng; Zhilian Su; Chao Pi; Yumeng Wei; Ling Zhao
Journal:  Arch Pharm Res       Date:  2022-07-31       Impact factor: 6.010

2.  The Flavonoid Baicalein Negatively Regulates Progesterone Target Genes in the Uterus in Vivo.

Authors:  Kailiang Li; Djeneba Diakite; Julia Austin; Jung-Ho Lee; Daniel D Lantvit; Brian T Murphy; Joanna E Burdette
Journal:  J Nat Prod       Date:  2021-12-22       Impact factor: 4.803

3.  Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis.

Authors:  Yanhong Wang; Qian Wang; Xibei Li; Gongwen Luo; Mou Shen; Jia Shi; Xueliang Wang; Lu Tang
Journal:  Drug Des Devel Ther       Date:  2021-01-22       Impact factor: 4.162

4.  Baicalein Represses Cervical Cancer Cell Growth, Cell Cycle Progression and Promotes Apoptosis via Blocking AKT/mTOR Pathway by the Regulation of circHIAT1/miR-19a-3p Axis.

Authors:  Jiaojiao Hu; Runkun Wang; Yi Liu; Jianbo Zhou; Ka Shen; Yun Dai
Journal:  Onco Targets Ther       Date:  2021-02-09       Impact factor: 4.147

Review 5.  Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives.

Authors:  Agata Gołąbek; Katarzyna Kowalska; Anna Olejnik
Journal:  Nutrients       Date:  2021-04-18       Impact factor: 5.717

Review 6.  Potential Mechanisms of Plant-Derived Natural Products in the Treatment of Cervical Cancer.

Authors:  Meizhu He; Lijie Xia; Jinyao Li
Journal:  Biomolecules       Date:  2021-10-18

7.  E2F transcription factor 1 elevates cyclin D1 expression by suppressing transcription of microRNA-107 to augment progression of glioma.

Authors:  Huan Xie; Shigang Lv; Zhaozhen Wang; Xinzhang Yuan
Journal:  Brain Behav       Date:  2021-11-10       Impact factor: 2.708

Review 8.  Regulation of Cell Signaling Pathways and Non-Coding RNAs by Baicalein in Different Cancers.

Authors:  Ammad Ahmad Farooqi; Gulnara Kapanova; Sundetgali Kalmakhanov; Gulnur Tanbayeva; Kairat S Zhakipbekov; Venera S Rakhmetova; Marat K Syzdykbayev
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

Review 9.  Advances in Anti-Cancer Activities of Flavonoids in Scutellariae radix: Perspectives on Mechanism.

Authors:  Yiqing Gu; Qi Zheng; Guifang Fan; Runping Liu
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.